BIOLASE, Inc.
BIOLASE, Inc. (BIOL) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BIOL · as of Jun 8, 2026
Key Statistics
Explore BIOLASE, Inc. Data
biol stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 83.3%
Competitors & Peers
biol competitorsBIOL
ACOR
AXDX
BLCM
CYTH
GBSStock Performance
Full HistoryAbout BIOLASE, Inc.
BIOLASE, Inc. along with its various divisions, operates as a global enterprise specializing in the creation, production, distribution, and sale of advanced laser systems. These technologies are spec…
what is biolase, inc. · biol stock overview · biolase, inc. company profile · who is biolase, inc. ceo · biol NASDAQ · biolase, inc. headquarters · biolase, inc. business segments
About Stock Overview & Key Data
BIOLASE, Inc. (BIOL) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Nov 12, 1992. As of the latest trading session, BIOL stock price is $0.02, with a market capitalization of $731,942. The stock has returned -98.81% over the past 12 months and -98.18% year-to-date.
According to 6 Wall Street analysts, the consensus rating for BIOLASE, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2023, BIOLASE, Inc. reported revenue of $49.2M and net income of -$20.6M. For detailed data — including BIOLASE, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, BIOLASE, Inc. (BIOL) stock price is $0.02. The stock is traded on NASDAQ under the ticker symbol BIOL. The 52-week range is $0.02 – $1.94.